Digitala Vetenskapliga Arkivet

Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Antibacterial Screening Reveals Multiple Potent Compounds Against Multidrug-Resistant Pathogens
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Biochemistry and Microbiology. (Diarmaid Hughes)
2025 (English)Independent thesis Advanced level (degree of Master (Two Years)), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

We characterized the microbiological properties of 204 Gram-positive-specific compounds from a previously unexplored novel compound library of compounds with minimum inhibitory concentration (MIC) ≤ 32 mg/L against Staphylococcus aureus). We identified 23 compounds with MICs 0.5 - 4 mg/L against S. aureus. All 23 retained activity against multidrug-resistant Gram-positive clinical isolates including MRSA, VRSA, hVISA, and VRE strains and no resistant mutants could be selected (frequency of resistance < 5,9 x 10-9). Most compounds were non-haemolytic (22/23, haemolysis <1%), but only 2/23 had an acceptable level of cytotoxicity (HepG2 IC50 > 50 µM). All 23 compounds lost activity in the presence of human serum (MIC >64 mg/L), suggesting high protein binding. We also characterized one Gram-negative-specific compound, JBL-198, active against efflux-defective Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii (MICs of 2, 16, 0,06 and 0,5 mg/L respectively). JBL-198 is non-haemolytic but cytotoxic against HepG2 (IC50 8,5 µM) and loses activity in the presence of human serum. Resistant mutants selected at 4xMIC occur at frequencies of »10-8 and »10-6. Whole genome sequencing revealed mutations in betI (osmolyte regulation) and baeS (efflux regulation) in E. coli; in PA4989 (lipopolysaccharide synthesis) in P. aeruginosa; and in adeL (efflux pump) in A. baumannii. The mutants showed low cross-resistance against six different antibiotic classes. The preliminary conclusion is that these compounds, have significant liabilities that would need to be overcome before they could be developed as antibiotics for systemic therapy, although topical applications might be a possible development path for the Gram-positive-specific compounds. 

Place, publisher, year, edition, pages
2025. , p. 50
Keywords [en]
Antimicrobial resistance, Antibacterial compounds, Multidrug-resistance, Drug screening, Staphylococcus aureus, antibiotic development.
National Category
Microbiology
Identifiers
URN: urn:nbn:se:uu:diva-563714OAI: oai:DiVA.org:uu-563714DiVA, id: diva2:1983746
Educational program
Master Programme in Infection Biology
Supervisors
Examiners
Available from: 2025-07-14 Created: 2025-07-12 Last updated: 2025-07-14Bibliographically approved

Open Access in DiVA

fulltext(2698 kB)206 downloads
File information
File name FULLTEXT01.pdfFile size 2698 kBChecksum SHA-512
64885e3dbb67eb8e86061f57510b858596f83f8dc0ba8be0853249147b75c7544415cecaf1216db52269d0b25eb1027a3049c7667a098736dca7a6e29b3d1205
Type fulltextMimetype application/pdf

By organisation
Department of Medical Biochemistry and Microbiology
Microbiology

Search outside of DiVA

GoogleGoogle Scholar
Total: 207 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
Total: 437 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf